Literature DB >> 17538894

Children in Burkina Faso who are protected by insecticide-treated materials are able to clear drug-resistant parasites better than unprotected children.

Diadier A Diallo1, Colin Sutherland, Issa Nebie, Amadou T Konate, Rosalynn Ord, Edith Ilboudo-Sanogo, Brian M Greenwood, Simon N Cousens.   

Abstract

BACKGROUND: It has been suggested that reducing exposure to malaria by vector control might impair the development of naturally acquired immunity to malaria. It is also thought that an individual's ability to clear drug-resistant malarial parasites after treatment is enhanced by acquired immunity.
METHODS: To investigate the hypothesis that insecticide-treated materials may affect the acquisition of immunity to malaria, we compared the ability of children living in villages in which insecticide-treated curtains (ITCs) had been used for 6-8 years to clear resistant parasites after treatment with chloroquine (CQ) with that of children living in unprotected villages.
RESULTS: A total of 1035 children aged 6-59 months with falciparum malaria were treated with CQ; 409 were subsequently identified as carrying parasites with the pfcrt-76T allele. More children from ITC villages cleared parasites harboring this allele than did children from non-ITC villages (34.1% vs. 24.0%; adjusted odds ratio [OR], 1.80 [95% confidence interval {CI}, 1.15-2.80]; P=.01). The difference in the clearance of parasites with the pfcrt-76T allele was seen in children aged 6-35 months (32.3% vs. 19.3%; adjusted OR, 2.34 [95% CI, 1.18-4.66]; P=.02) but not in older children (37.3% vs. 37.0%; adjusted OR, 1.09 [95% CI, 0.56-2.10]; P=.97). Rates of adequate clinical response among children carrying parasites with the pfcrt-76T allele were similar in ITC and non-ITC villages (75.1% vs. 68.6%; adjusted OR, 1.21 [95% CI, 0.61-2.39]; P=.58).
CONCLUSION: Our data suggest that the children who were protected from malaria by ITCs acquired functional immunity more rapidly than did the control children.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538894     DOI: 10.1086/518252

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?

Authors:  Colin J Sutherland; Hamza Babiker; Margaret J Mackinnon; Lisa Ranford-Cartwright; Badria Babiker El Sayed
Journal:  Parasitology       Date:  2011-08-03       Impact factor: 3.234

2.  Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique.

Authors:  Diana Quelhas; Laura Puyol; Llorenç Quintó; Elisa Serra-Casas; Tacilta Nhampossa; Eusebio Macete; Pedro Aide; Alfredo Mayor; Inacio Mandomando; Sergi Sanz; John J Aponte; Virander S Chauhan; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez; Carlota Dobaño
Journal:  Clin Vaccine Immunol       Date:  2008-05-21

3.  Persistent detection of Plasmodium falciparum, P. malariae, P. ovale curtisi and P. ovale wallikeri after ACT treatment of asymptomatic Ghanaian school-children.

Authors:  Bismarck Dinko; Mary C Oguike; John A Larbi; Teun Bousema; Colin J Sutherland
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2013-01-19       Impact factor: 4.077

4.  Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data.

Authors:  Anne E P Frosch; Meera Venkatesan; Miriam K Laufer
Journal:  Malar J       Date:  2011-05-09       Impact factor: 2.979

5.  Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications.

Authors:  Reem A Mubjer; Ahmed A Adeel; Michael L Chance; Amir A Hassan
Journal:  Malar J       Date:  2011-08-21       Impact factor: 2.979

6.  Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger.

Authors:  Maman Laminou Ibrahim; Nicolas Steenkeste; Nimol Khim; Hadiza Hassane Adam; Lassana Konaté; Jean-Yves Coppée; Fredéric Ariey; Jean-Bernard Duchemin
Journal:  Malar J       Date:  2009-02-23       Impact factor: 2.979

7.  The high burden of infant deaths in rural Burkina Faso: a prospective community-based cohort study.

Authors:  Abdoulaye Hama Diallo; Nicolas Meda; Halvor Sommerfelt; Germain S Traore; Simon Cousens; Thorkild Tylleskar
Journal:  BMC Public Health       Date:  2012-09-05       Impact factor: 3.295

8.  How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions?

Authors:  Colin J Sutherland; Christopher J Drakeley; David Schellenberg
Journal:  Malar J       Date:  2007-12-04       Impact factor: 2.979

9.  Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.

Authors:  Hamma Maiga; Estrella Lasry; Modibo Diarra; Issaka Sagara; Amadou Bamadio; Aliou Traore; Samba Coumare; Soma Bahonan; Boubou Sangare; Yeyia Dicko; Nouhoum Diallo; Aly Tembely; Djibril Traore; Hamidou Niangaly; François Dao; Aboubecrine Haidara; Alassane Dicko; Ogobara K Doumbo; Abdoulaye A Djimde
Journal:  PLoS One       Date:  2016-09-23       Impact factor: 3.240

10.  High production of pro-inflammatory cytokines by maternal blood mononuclear cells is associated with reduced maternal malaria but increased cord blood infection.

Authors:  Carlota Dobaño; Tamara Berthoud; Maria Nelia Manaca; Augusto Nhabomba; Caterina Guinovart; Ruth Aguilar; Arnoldo Barbosa; Penny Groves; Mauricio H Rodríguez; Alfons Jimenez; Lazaro M Quimice; John J Aponte; Jaume Ordi; Denise L Doolan; Alfredo Mayor; Pedro L Alonso
Journal:  Malar J       Date:  2018-05-10       Impact factor: 2.979

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.